ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,012.28
-1.46%
Dow Jones
44,713.58
0.65%
US Dollar vs MXN
20.6483
-0.46%
Brent Oil
76.715
0.58%
Bitcoin
102,702.58
0.62%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Cartesian Therapeutics Inc (RNAC) Cotización

Cartesian Therapeutics Inc

Cartesian Therapeutics Inc (RNAC)

NASDAQ
19.42
0.22
(1.15%)
Cerrado 27 Enero 3:00PM
Delayed by 15 minutes
19.10
-0.32
( -1.65% )
Pre Mercado: 4:02AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
19.10
Postura de Compra
16.71
Postura de Venta
24.80
Volume Operado de la Acción
325
0.00 Rango del Día 0.00
11.665 Rango de 52 semanas 41.87
Capitalización de Mercado [m]
485.425M
Precio Anterior
19.42
Precio de Apertura
-
Hora
1
@
19.11
Última hora de negociación
04:02:58
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
127,570
Acciones en circulación
25,414,898
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.25
Beneficio por acción (BPA)
-8.64
turnover
26M
Beneficio neto
-219.71M

Acerca de Cartesian Therapeutics Inc

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.selectabio.com
Sede
Wilmington, Delaware, USA
Fundado
-
Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAC. The last closing price for Cartesian Therapeutics was US$19.42. Over the last year, Cartesian Therapeutics shares have traded in a share price range of US$ 11.665 to US$ 41.87.

Cartesian Therapeutics currently has 25,414,898 shares in issue. The market capitalisation of Cartesian Therapeutics is US$493.56 million. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -2.25.

RNAC Últimas noticias

Más noticias

Form 8-K - Current report

23 horas hace
Edgar (US Regulatory)

Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis

FREDERICK, Md., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune...

23 horas hace
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

13 Enero 2025
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

13 Enero 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Enero 2025
Edgar (US Regulatory)

Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25 Deepening responses observed over time in Descartes-08-treated participants in Phase 2b trial in myasthenia...

13 Enero 2025
GlobeNewswire Inc.

Form POS AM - Post-Effective amendments for registration statement

10 Enero 2025
Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement

10 Enero 2025
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

09 Enero 2025
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

09 Enero 2025
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.35-1.7994858611819.4519.99918.226872119.4138541CS
40.764.143947655418.3420.1216.49430917.93358801CS
12-0.03-0.15682174594919.1326.515.512757019.02231031CS
261.729.8964326812417.3826.512.4810921518.42485293CS
52-3.403-15.122428120722.50341.8711.66522709119.51297397CS
156-5.095-21.058069849124.19542.611.66535495522.59544858CS
260-5.095-21.058069849124.19542.611.66535495522.59544858CS

RNAC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cartesian Therapeutics?
El precio actual de las acciones de Cartesian Therapeutics es US$ 19.10
¿Cuántas acciones de Cartesian Therapeutics están en circulación?
Cartesian Therapeutics tiene 25,414,898 acciones en circulación
¿Cuál es la capitalización de mercado de Cartesian Therapeutics?
La capitalización de mercado de Cartesian Therapeutics es USD 493.56M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cartesian Therapeutics?
Cartesian Therapeutics ha negociado en un rango de US$ 11.665 a US$ 41.87 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cartesian Therapeutics?
El ratio precio/beneficio de Cartesian Therapeutics es -2.25
¿Cuál es el ratio de efectivo a ventas de Cartesian Therapeutics?
El ratio de efectivo a ventas de Cartesian Therapeutics es 18.98
¿Cuál es la moneda de reporte de Cartesian Therapeutics?
Cartesian Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Cartesian Therapeutics?
El último ingresos anual de Cartesian Therapeutics es USD 26M
¿Cuál es el último beneficio anual de Cartesian Therapeutics?
El último beneficio anual de Cartesian Therapeutics es USD -219.71M
¿Cuál es la dirección registrada de Cartesian Therapeutics?
La dirección registrada de Cartesian Therapeutics es CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Cartesian Therapeutics?
La dirección del sitio web de Cartesian Therapeutics es www.selectabio.com
¿En qué sector industrial opera Cartesian Therapeutics?
Cartesian Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BACKIMAC Holdings Inc
US$ 1.71
(106.27%)
14.46M
CDTConduit Pharmaceuticals Inc
US$ 5.55
(68.18%)
231.25k
FORLFour Leaf Acquisition Corporation
US$ 17.91
(60.20%)
12
GDSTGoldenstone Acquisition Ltd
US$ 18.55
(59.09%)
18
IROHIron Horse Acquisition Corporation
US$ 16.47
(58.98%)
6
TMCITreace Medical Concepts Inc
US$ 4.00
(-58.76%)
197
HCVIHennessy Capital Investment Corporation VI
US$ 6.01
(-43.89%)
5
CCECCapital Clean Energy Carriers Corporation
US$ 13.01
(-29.68%)
8
FSTRL B Foster Company
US$ 19.12
(-29.21%)
14
BLFSBioLife Solutions Inc
US$ 20.12
(-28.85%)
8
HEPAHepion Pharmaceuticals Inc
US$ 0.22
(33.33%)
17.7M
BACKIMAC Holdings Inc
US$ 1.71
(106.27%)
14.46M
YIBOPlanet Image International Ltd
US$ 4.84
(57.14%)
7.43M
ZKINZK International Group Co Ltd
US$ 1.05
(54.41%)
6.89M
NVDANVIDIA Corporation
US$ 124.56
(5.18%)
5.33M

Discusión

Ver feed completo
facts_matter14 facts_matter14 3 minutos hace
Hers the pitch; another swing and a miss……..

Only needed 150% more revenue to be right about this pump.





https://investorshub.advfn.com/uimage/uploads/2025/1/26/czcimIMG_6273.jpeg



https://investorshub.advfn.
SRMX
mahatmapaul mahatmapaul 4 minutos hace
This post of Kool Aid's should be stickied!
SPZI
oldstocks oldstocks 5 minutos hace
He has made business decisions building the casinos that a lot of companies in Atlantic County lost a lot of money on including my family. He is best in his position now. Given the choices of voting options a lot of them same people voted for him hoping he can make America better.
We do not
AFFU
chicks0123 chicks0123 7 minutos hace
Good morning CLNVERS 
CLNV
ArcCeliaSkye ArcCeliaSkye 7 minutos hace
He has been deceiving everyone here, and this fraud is happening in broad daylight, yet no one is making an effort to hold him accountable or put him behind bars. Are we so indifferent that we allow this man to exploit the hard-earned money of investors and drain the livelihood and well-being of emp
ITUP
glenn1919 glenn1919 8 minutos hace
athe................................https://stockcharts.com/h-sc/ui?s=athe&p=W&b=5&g=0&id=p86431144783
ATHE
MartinLutherKing MartinLutherKing 8 minutos hace
Green light fast track 🚀🚀🚀TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15 2024 - 9:00AM


Share On Facebook

TransCode Therapeutics, In
RNAZ
JSmith5 JSmith5 10 minutos hace
Don't have a choice to show the bird to the folks who has to approve his selection

Exactly! We don't want to go to the tie-breaker again. He will respond with the exact same answers as did Treasury as the response is being prepared by the same members of the Transition team. They w
FNMA
SkeBallLarry SkeBallLarry 10 minutos hace
US Border Patrol and Mexican cartel members trade >

gunfire at southern border: report >
https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
SkeBallLarry SkeBallLarry 11 minutos hace
US Border Patrol and Mexican cartel members trade >

gunfire at southern border: report >
https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
SkeBallLarry SkeBallLarry 12 minutos hace
US Border Patrol and Mexican cartel members trade >

gunfire at southern border: report >
https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
facts_matter14 facts_matter14 12 minutos hace
WOW, this is INCREDIBLE!!

On 8-21-21, pps was .0014

41 months later, what a BLAST OFF it was!!

Wasn’t very little selling, it was very little buying. Duh!







https://investorshub.advfn.com/uimage
SRMX
SkeBallLarry SkeBallLarry 12 minutos hace
US Border Patrol and Mexican cartel members trade >

gunfire at southern border: report >
https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
sab63090 sab63090 13 minutos hace
Yes on BDX, but sorry for our Bills...Cook did well, Allen, too, but only used Shakir for a good play....it was close except for some mistakes...next year
BDX
SkeBallLarry SkeBallLarry 13 minutos hace
US Border Patrol and Mexican cartel members trade >

gunfire at southern border: report >
https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
Number sleven Number sleven 15 minutos hace
https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
Sleven,
AMRN
allezlOM allezlOM 23 minutos hace
$DBMM , you could be true ➡️"13f-2's compliance date is Jan 2, 2025. The initial report required by Rule 13f-2, which will cover gross short positions that exceeded the applicable threshold during January 2025 (which may include gross short positions entered into prior to January 2025), is due Feb.
DBMM
sab63090 sab63090 24 minutos hace
I'm caught up on this board now...so I will now observe for some later day trades to see where I might be right or wrong...🤔
AVXL
hedges54 hedges54 26 minutos hace
towards the end of Core Chronicles 7 he mentioned that there was going to be an announcement that was going to be on Blomberg FOX CBS NBC etc. but could not mention it yet because of confidenceality .I hope that comes up again soon
ARAT
sab63090 sab63090 27 minutos hace
Steady T
I not only agree, but you might consider that when the stock is strong that they take advantage and actually buy and enhance the up move to get short again using the advantage of the delayed calendar reporting; tactfully using that...those chief traders know all the tricks.
MCD WMT
eagle8 eagle8 27 minutos hace
Frank Nez
@FNez_Blogger
·
12h
🚨JUST IN: CFO of Massive Hedge Fund Will Now Serve 8 Years in Prison
https://franknez.com/cfo-of-massive-hedge-fund-will-now-serve-8-years-in-prison/
NWBO

Su Consulta Reciente

NASDAQ
RNAC
Cartesian Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados